In the United States, current guidelines recommend endoscopic evaluation of worrisome upper gastrointestinal symptoms such as unintended weight loss, iron deficiency anemia, and dysphagia. [10] [11] [12] [13] [14] [15] [16] [17] Unfortunately, patients with potentially curable gastric cancer often do not have these alarm symptoms and their presence heralds incurable disease. [18] [19] [20] Richer targets for evaluation are gastric precursor lesions such as proximal and multifocal gastric intestinal metaplasia (GIM). Existing American and European guidelines on the evaluation for gastric precursor lesions are lacking and are also based on a predominately Caucasian population at very low risk of gastric cancer.
While guidelines advise endoscopic surveillance in those with established multifocal GIM, they do not address which patients should be evaluated for precursors in the first place. 21, 22 Our primary aim was to determine whether endoscopy guided by high-risk indications is adequate to detect gastric precursor lesions and malignancy in a predominantly Asian and Hispanic American population.
| ME THODS

| Patients
Approval from the University of Southern California Health Sciences
Institutional Review Board was obtained prior to initiation of study activities. We reviewed consecutive patients who underwent en- Table 1 ). These definitions matched those used in previous work using the CORI database. 23 The CORI reporting software was utilized by multiple centers in the United States to simultaneously document procedures and gather information for the National Endoscopic Database (NED). Given that our analysis required granular clinical and pathologic information in addition to endoscopic findings, we used CORI only to identify the patients from the Los Angeles County Hospital (not entire NED). We then manually reviewed the entire medical record for all patients described in this report. Additionally, given the CORI configuration at the Los Angeles County Hospital, only the primary indication for endoscopy was entered by the endoscopist and available for analysis; thus secondary indications could not be studied.
As our aim was to determine the predictive role of low-vs high- 
| Outcomes
The primary outcome was the proportion of patients with GIM, highrisk GIM, and cancer who had a high-risk indication relative to those with benign disease. Additional outcomes included the proportion of patients with gastric cancer and precursor lesions who presented with specific indications (ie, weight loss) relative to those with benign disease. We also compared the proportion of patients with GIM, high-risk GIM, and cancer relative to those with benign disease who were male, Hispanic or Asian, and >50 years of age.
| Statistical analysis
Baseline patient characteristics and outcomes were described using proportions for categorical variables and means vs medians (depending on distribution) for continuous variables. Dysplasia and atrophy were reported in a descriptive fashion but not included in the analysis given the small numbers of patients in these categories. Univariate multinomial logistic regression models were used to evaluate the relationship between high-risk indications and the histologic subtypes. subtypes (benign, GIM, high-risk GIM, and cancer). The age of 50 was chosen as the cutoff given the importance of this age for colorectal cancer screening guidelines and the feasibility of combining an upper endoscopy and colonoscopy in a routine exam. 25 Separate models were used to compare associations between specific indications and histology. We then performed sensitivity analysis assessing these associations only among patients who underwent gastric biopsy. This was achieved by repeating the primary multinomial univariate and multivariate logistic regression analyses after exempting all patients in whom biopsies were not performed. Statistical analysis was performed using Stata 14 (College Station, TX).
| RE SULTS
| Population
We Table 1) . Most of the cohort was female (62%) and Hispanic (75%) ( Table 2 ). The average age was 54.2 ± 10.5 years old.
Gastric biopsy was performed in 2412 (65%) patients and was not performed in the remainder of the cases due to a normal appearing stomach on high-definition white light endoscopy. The combination of endoscopic evaluation and biopsy revealed that 3155 (85.4%) of patients had benign findings ( 
| Additional predictors of GIM and gastric cancer
In multivariate analysis, age >50 years old was predictive of GIM (OR (9) 2 (9) 2 (9) a Mucosa had normal visual appearance among patients in whom biopsy was not obtained.
not GIM or high-risk GIM. In univariate and multivariate sub-analysis, no specific indication predicted GIM or high-risk GIM (Table S1 ). 
| Sensitivity analysis
In the sensitivity analysis exempting the 1287 patients in whom biopsies were not performed from our multivariate models, we did not observe a material difference in our primary results (Table S2) . 
| D ISCUSS I ON
Gastric cancer has been proposed to arise through a sequence of histologic changes starting with H. pylori gastritis followed by atrophy, intestinal metaplasia, dysplasia, and carcinoma. 26 addressed in several large Asian cohorts. 4, 33, 34 For example, given known age-related risks, screening is typically initiated at age 40 in Korea with follow-up studies every 1-2 years thereafter. 4, 31 While it is impossible to assess the precise impact of screening programs, work by Hosokawa et al 35 suggests that patients who underwent early screening endoscopies had a relative risk of gastric cancer death of 0.35 compared to patients who did not receive screening.
Presumably this results from detection of early and treatable gastric cancer and precursor lesions. In contrast, our study diagnosed 160 patients over the course of four years with gastric cancer, 108
(68%) of which already had metastatic disease at presentation and 8 patients (5%) who had such advanced disease that they passed away prior to cancer staging. Like other screening tests, cost and resource utilization must be considered. 36 A decision analytical model by Gupta et al 37 showed that the addition of a one-time screening endoscopy for upper GI cancer at time of colonoscopy cost $95 559
per quality-adjusted life year saved which is comparable to the cost for other types of cancers that we routinely screen. Among patients with extensive metaplasia endoscopic surveillance every 3 years appears to be cost-effective in cost utility analysis. have also been missed if endoscopies were only performed for highrisk indications. We found that poorly differentiated or diffuse type gastric adenocarcinoma by Lauren classification was the most common subtype of gastric cancer found in our study group (60.6%). 39 The most plausible explanation is that we serve a patient population where many of our patients have limited access to healthcare and typically harbor advanced disease accompanied by histologic loss of differentiation.
Our study has several limitations. The most significant was that biopsies were targeted only by white light. In our recently reported blinded tandem trial, we demonstrated that the addition of narrow-band imaging (NBI) and Sydney biopsy protocol to white light in patients with gastric symptoms triples the rate of gastric metaplasia detection from 9% to 27%. 40 This finding explains the relatively low rates of GIM, 10%, and high-risk GIM 7%, relative to the high rate of gastric carcinoma, 4% in which only white light was used to target biopsies in patients with gastric indications. We have also observed that atrophy is detected with greater fidelity when biopsies from the antrum and body of the stomach are separated. The relatively low numbers of patients with atrophy reported in this large retrospective series likely reflect the tendency to combine samples from the antrum and body at our center. It also may reflect the propensity of pathologists at our high-volume center to focus on the most diffuse or serious pathology- 42, 43 This risk is much greater in Hispanics as compared to their Caucasian counterparts. 42 Our results indicate that performing upper endoscopy only for the presence of alarm symptoms fails to detect a significant number of GIM and is only marginally better for detecting malignancy.
Patients who originate from H. pylori endemic areas including Central and South America and Asia who are over the age of 50 should be considered for endoscopy whether they present with low or highrisk symptoms. Screening in these well-defined populations in the United States by endoscopy merits large prospective controlled studies. A more cost-effective strategy may involve risk-stratifying patients by testing for H. pylori exposure or possibly pepsinogen levels followed by upper endoscopy. 44 Such a tailored approach could be integrated into the colorectal cancer screening process for patients aged 50 or greater.
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